Sabine Gilch, PhD
BSc Molecular Biology - Johannes Gutenberg University, Mainz, GermanyMSc Molecular Biotechnology - Technical University of Munich, Munich, Germany
PhD Molecular Biotechnology/Prion Biology - Technical University, Munich, Germany
Areas of Research
Prion diseases, cell biology of prion infection, chronic wasting disease, prion strains
Prion diseases are unique neurodegenrative diseases for several reasons: first, they are caused by fascinating infectious agents called prions, which are infectious proteins that replicate without genetic information such as DNA or RNA; second, they can have 3 different etiologies (sporadic, genetic, infectious) in humans; third, while there are other neurodegenerative diseases associated with protein misfolding (e.g. Alzheimer's disease) also referred to as 'prion-like' disorders, only prion diseases are naturally transmissible from human-to-human, animal-to-animal and even animal-to-human. Most well-known examples are Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy (mad cow disease) in cattle and chronic wasting disease (CWD) in cervids. I have been studying prions for more than 20 years and joined UCVM in 2013 as Tier 2 Canada Research Chair in Prion Disease Research. We use cell culture and rodent models or prion disease to understand how prion replication affects neuronal cholesterol metabolism and vesicle trafficking in the endocytic pathway with the goal to identify new drug targets and therapies for prion diseases, which are strictly fatal and not treatable to date. For example, my group has introduce peptide aptamers as a new class of anti-prion agents, which we currently evaluate for their effects on the pathogenesis of Alzheimer's disease. Further, we study the diversity of chronic wasting disease strains and have established new mouse models that allow us to gain understanding of strain selection and adaptation upon natural infection routes. This is highly relevant in order to determine transmission profiles, including the possibility of cervid-to-human or cervid-to-livestock transmission.
Prion diseases are unique neurodegenrative diseases for several reasons: first, they are caused by fascinating infectious agents called prions, which are infectious proteins that replicate without genetic information such as DNA or RNA; second, they can have 3 different etiologies (sporadic, genetic, infectious) in humans; third, while there are other neurodegenerative diseases associated with protein misfolding (e.g. Alzheimer's disease) also referred to as 'prion-like' disorders, only prion diseases are naturally transmissible from human-to-human, animal-to-animal and even animal-to-human. Most well-known examples are Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy (mad cow disease) in cattle and chronic wasting disease (CWD) in cervids. I have been studying prions for more than 20 years and joined UCVM in 2013 as Tier 2 Canada Research Chair in Prion Disease Research. We use cell culture and rodent models or prion disease to understand how prion replication affects neuronal cholesterol metabolism and vesicle trafficking in the endocytic pathway with the goal to identify new drug targets and therapies for prion diseases, which are strictly fatal and not treatable to date. For example, my group has introduce peptide aptamers as a new class of anti-prion agents, which we currently evaluate for their effects on the pathogenesis of Alzheimer's disease. Further, we study the diversity of chronic wasting disease strains and have established new mouse models that allow us to gain understanding of strain selection and adaptation upon natural infection routes. This is highly relevant in order to determine transmission profiles, including the possibility of cervid-to-human or cervid-to-livestock transmission.
Supervising degrees
Veterinary Medical Sciences - Doctoral: Seeking Students
Biochemistry and Molecular Biology - Doctoral: Seeking Students
Veterinary Medical Sciences - Masters: Accepting Inquiries
Biochemistry and Molecular Biology - Masters: Accepting Inquiries
Contact this supervisor
Complete the following form if you are interested in working with this supervisor for your Graduate Program. All fields are required, unless indicated otherwise.
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.